WeVote
Log In

Bill

Bill

SB 2664

Relating to the university advisory committee of and procedure for making awards by the Cancer Prevention and Research Institute of Texas.

89th Legislature (2025) Introduced by Chuy Hinojosa

SB 2664 restructures CPRIT's university advisory committee and modifies its cancer research funding award procedures, affecting how Texas distributes hundreds of millions in state research grants.

Referred to Health & Human Services
#cancerprevention&researchinstituteoftexas(v0778) #schoolofmedicineattheuniversityoftexasatriograndevalley(u0240) #statefinances--management&control(i0748)
0
WeVote Research Nonpartisan
Bill Summary · SB 2664

Legislative bill overview

SB 2664 modifies the governance structure and award-making procedures of the Cancer Prevention and Research Institute of Texas (CPRIT) by restructuring its university advisory committee and establishing new guidelines for how the institute distributes research funding and grants. The bill adjusts the composition and responsibilities of the advisory body that recommends funding decisions to CPRIT's leadership.

Why is this important

CPRIT distributes hundreds of millions in state funding for cancer research and prevention across Texas institutions. Changes to how this advisory committee operates and awards are made directly affect which researchers receive grants, which universities benefit from funding, and ultimately which cancer research projects advance in the state. This can influence the direction of medical research and economic development in Texas's life sciences sector.

Potential points of contention

  • Committee composition disputes: Changes to advisory committee membership could favor certain universities or research institutions over others, creating concerns about equitable representation and fair access to funding
  • Award-making transparency: New procedures for making awards may either increase or decrease transparency depending on specific changes, affecting stakeholder confidence in the process
  • Research priorities: Restructuring decision-making authority could shift which types of cancer research receive priority, potentially disadvantaging some researchers or neglecting certain cancer types

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.